Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 205 to 214 of 214 entries
Sorted by: Best Match Show Resources per page
[No title available]

Autophagy

Cong Y, So V, Tijssen MAJ, Verbeek DS, Reggiori F, Mauthe M.
PMID: 33843443
Autophagy. 2021 Dec;17(12):3908-3923. doi: 10.1080/15548627.2021.1899669. Epub 2021 Apr 12.

The

Cite
Cong Y, So V, Tijssen MAJ, et al. . Autophagy. 2021;17(12):3908-3923doi: 10.1080/15548627.2021.1899669.
Cong, Y., So, V., Tijssen, M. A. J., Verbeek, D. S., Reggiori, F., & Mauthe, M. (2021). . Autophagy, 17(12), 3908-3923. https://doi.org/10.1080/15548627.2021.1899669
Cong, Yingying, et al. "." Autophagy vol. 17,12 (2021): 3908-3923. doi: https://doi.org/10.1080/15548627.2021.1899669
Cong Y, So V, Tijssen MAJ, Verbeek DS, Reggiori F, Mauthe M. . Autophagy. 2021 Dec;17(12):3908-3923. doi: 10.1080/15548627.2021.1899669. Epub 2021 Apr 12. PMID: 33843443.
Copy Download .nbib Format: NLM
The Need to Consider Relocations WITHIN Long-Term Care.

Journal of the American Medical Directors Association

de Boer B, Caljouw M, Landeweer E, Perry M, Stoop A, Groen W, Schols J, Verbeek HV.
PMID: 34932987
J Am Med Dir Assoc. 2021 Dec 18; doi: 10.1016/j.jamda.2021.11.021. Epub 2021 Dec 18.

No abstract available.

Cite
de Boer B, Caljouw M, Landeweer E, et al. The Need to Consider Relocations WITHIN Long-Term Care. J Am Med Dir Assoc. 2021;doi: 10.1016/j.jamda.2021.11.021.
de Boer, B., Caljouw, M., Landeweer, E., Perry, M., Stoop, A., Groen, W., Schols, J., Verbeek, H. V. (2021). The Need to Consider Relocations WITHIN Long-Term Care. Journal of the American Medical Directors Association, . https://doi.org/10.1016/j.jamda.2021.11.021
de Boer, Bram, et al. "The Need to Consider Relocations WITHIN Long-Term Care." Journal of the American Medical Directors Association vol. (2021). doi: https://doi.org/10.1016/j.jamda.2021.11.021
de Boer B, Caljouw M, Landeweer E, Perry M, Stoop A, Groen W, Schols J, Verbeek HV. The Need to Consider Relocations WITHIN Long-Term Care. J Am Med Dir Assoc. 2021 Dec 18; doi: 10.1016/j.jamda.2021.11.021. Epub 2021 Dec 18. PMID: 34932987.
Copy Download .nbib Format: NLM
Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe.

BMJ open

Gerritsen SE, Maras A, van Bodegom LS, Overbeek MM, Verhulst FC, Wolke D, Appleton R, Bertani A, Cataldo MG, Conti P, Da Fonseca D, Davidović N, Dodig-Ćurković K, Ferrari C, Fiori F, Franić T, Gatherer C, De Girolamo G, Heaney N, Hendrickx G, Kolozsvari A, Levi FM, Lievesley K, Madan J, Martinelli O, Mastroianni M, Maurice V, McNicholas F, O'Hara L, Paul M, Purper-Ouakil D, de Roeck V, Russet F, Saam MC, Sagar-Ouriaghli I, Santosh PJ, Sartor A, Schandrin A, Schulze UME, Signorini G, Singh SP, Singh J, Street C, Tah P, Tanase E, Tremmery S, Tuffrey A, Tuomainen H, van Amelsvoort TAMJ, Wilson A, Walker L, Dieleman GC.
PMID: 34916319
BMJ Open. 2021 Dec 16;11(12):e053373. doi: 10.1136/bmjopen-2021-053373.

PURPOSE: The presence of distinct child and adolescent mental health services (CAMHS) and adult mental health services (AMHS) impacts continuity of mental health treatment for young people. However, we do not know the extent of discontinuity of care in...

Cite
Gerritsen SE, Maras A, van Bodegom LS, et al. Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe. BMJ Open. 2021;11(12):e053373doi: 10.1136/bmjopen-2021-053373.
Gerritsen, S. E., Maras, A., van Bodegom, L. S., Overbeek, M. M., Verhulst, F. C., Wolke, D., Appleton, R., Bertani, A., Cataldo, M. G., Conti, P., Da Fonseca, D., Davidović, N., Dodig-Ćurković, K., Ferrari, C., Fiori, F., Franić, T., Gatherer, C., De Girolamo, G., Heaney, N., Hendrickx, G., Kolozsvari, A., Levi, F. M., Lievesley, K., Madan, J., Martinelli, O., Mastroianni, M., Maurice, V., McNicholas, F., O'Hara, L., Paul, M., Purper-Ouakil, D., de Roeck, V., Russet, F., Saam, M. C., Sagar-Ouriaghli, I., Santosh, P. J., Sartor, A., Schandrin, A., Schulze, U. M. E., Signorini, G., Singh, S. P., Singh, J., Street, C., Tah, P., Tanase, E., Tremmery, S., Tuffrey, A., Tuomainen, H., van Amelsvoort, T. A. M. J., Wilson, A., Walker, L., Dieleman, G. C. (2021). Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe. BMJ open, 11(12), e053373. https://doi.org/10.1136/bmjopen-2021-053373
Gerritsen, Suzanne E, et al. "Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe." BMJ open vol. 11,12 (2021): e053373. doi: https://doi.org/10.1136/bmjopen-2021-053373
Gerritsen SE, Maras A, van Bodegom LS, Overbeek MM, Verhulst FC, Wolke D, Appleton R, Bertani A, Cataldo MG, Conti P, Da Fonseca D, Davidović N, Dodig-Ćurković K, Ferrari C, Fiori F, Franić T, Gatherer C, De Girolamo G, Heaney N, Hendrickx G, Kolozsvari A, Levi FM, Lievesley K, Madan J, Martinelli O, Mastroianni M, Maurice V, McNicholas F, O'Hara L, Paul M, Purper-Ouakil D, de Roeck V, Russet F, Saam MC, Sagar-Ouriaghli I, Santosh PJ, Sartor A, Schandrin A, Schulze UME, Signorini G, Singh SP, Singh J, Street C, Tah P, Tanase E, Tremmery S, Tuffrey A, Tuomainen H, van Amelsvoort TAMJ, Wilson A, Walker L, Dieleman GC. Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe. BMJ Open. 2021 Dec 16;11(12):e053373. doi: 10.1136/bmjopen-2021-053373. PMID: 34916319.
Copy Download .nbib Format: NLM
[No title available]

Autophagy

Cong Y, So V, Tijssen MAJ, Verbeek DS, Reggiori F, Mauthe M.
PMID: 33843443
Autophagy. 2021 Dec;17(12):3908-3923. doi: 10.1080/15548627.2021.1899669. Epub 2021 Apr 12.

The

Cite
Cong Y, So V, Tijssen MAJ, et al. . Autophagy. 2021;17(12):3908-3923doi: 10.1080/15548627.2021.1899669.
Cong, Y., So, V., Tijssen, M. A. J., Verbeek, D. S., Reggiori, F., & Mauthe, M. (2021). . Autophagy, 17(12), 3908-3923. https://doi.org/10.1080/15548627.2021.1899669
Cong, Yingying, et al. "." Autophagy vol. 17,12 (2021): 3908-3923. doi: https://doi.org/10.1080/15548627.2021.1899669
Cong Y, So V, Tijssen MAJ, Verbeek DS, Reggiori F, Mauthe M. . Autophagy. 2021 Dec;17(12):3908-3923. doi: 10.1080/15548627.2021.1899669. Epub 2021 Apr 12. PMID: 33843443; PMCID: PMC8726670.
Copy Download .nbib Format: NLM
Should Codeine Still be Considered a WHO Essential Medicine?.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Singu B, Verbeeck RK.
PMID: 34192509
J Pharm Pharm Sci. 2021;24:329-335. doi: 10.18433/jpps31639.

Codeine continues to be widely used as an analgesic, antidiarrhoeal and antitussive agent. Its analgesic effect depends on its biotransformation to morphine, a strong opioid. The highly variable biotransformation of codeine to morphine, catalysed by CYP2D6, underlies the pronounced...

Cite
Singu B, Verbeeck RK. Should Codeine Still be Considered a WHO Essential Medicine?. J Pharm Pharm Sci. 2021;24:329-335doi: 10.18433/jpps31639.
Singu, B., & Verbeeck, R. K. (2021). Should Codeine Still be Considered a WHO Essential Medicine?. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 24329-335. https://doi.org/10.18433/jpps31639
Singu, Boni, and Verbeeck, Roger K. "Should Codeine Still be Considered a WHO Essential Medicine?." Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques vol. 24 (2021): 329-335. doi: https://doi.org/10.18433/jpps31639
Singu B, Verbeeck RK. Should Codeine Still be Considered a WHO Essential Medicine?. J Pharm Pharm Sci. 2021;24:329-335. doi: 10.18433/jpps31639. PMID: 34192509.
Copy Download .nbib Format: NLM
Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe.

BMJ open

Gerritsen SE, Maras A, van Bodegom LS, Overbeek MM, Verhulst FC, Wolke D, Appleton R, Bertani A, Cataldo MG, Conti P, Da Fonseca D, Davidović N, Dodig-Ćurković K, Ferrari C, Fiori F, Franić T, Gatherer C, De Girolamo G, Heaney N, Hendrickx G, Kolozsvari A, Levi FM, Lievesley K, Madan J, Martinelli O, Mastroianni M, Maurice V, McNicholas F, O'Hara L, Paul M, Purper-Ouakil D, de Roeck V, Russet F, Saam MC, Sagar-Ouriaghli I, Santosh PJ, Sartor A, Schandrin A, Schulze UME, Signorini G, Singh SP, Singh J, Street C, Tah P, Tanase E, Tremmery S, Tuffrey A, Tuomainen H, van Amelsvoort TAMJ, Wilson A, Walker L, Dieleman GC.
PMID: 34916319
BMJ Open. 2021 Dec 16;11(12):e053373. doi: 10.1136/bmjopen-2021-053373.

PURPOSE: The presence of distinct child and adolescent mental health services (CAMHS) and adult mental health services (AMHS) impacts continuity of mental health treatment for young people. However, we do not know the extent of discontinuity of care in...

Cite
Gerritsen SE, Maras A, van Bodegom LS, et al. Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe. BMJ Open. 2021;11(12):e053373doi: 10.1136/bmjopen-2021-053373.
Gerritsen, S. E., Maras, A., van Bodegom, L. S., Overbeek, M. M., Verhulst, F. C., Wolke, D., Appleton, R., Bertani, A., Cataldo, M. G., Conti, P., Da Fonseca, D., Davidović, N., Dodig-Ćurković, K., Ferrari, C., Fiori, F., Franić, T., Gatherer, C., De Girolamo, G., Heaney, N., Hendrickx, G., Kolozsvari, A., Levi, F. M., Lievesley, K., Madan, J., Martinelli, O., Mastroianni, M., Maurice, V., McNicholas, F., O'Hara, L., Paul, M., Purper-Ouakil, D., de Roeck, V., Russet, F., Saam, M. C., Sagar-Ouriaghli, I., Santosh, P. J., Sartor, A., Schandrin, A., Schulze, U. M. E., Signorini, G., Singh, S. P., Singh, J., Street, C., Tah, P., Tanase, E., Tremmery, S., Tuffrey, A., Tuomainen, H., van Amelsvoort, T. A. M. J., Wilson, A., Walker, L., Dieleman, G. C. (2021). Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe. BMJ open, 11(12), e053373. https://doi.org/10.1136/bmjopen-2021-053373
Gerritsen, Suzanne E, et al. "Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe." BMJ open vol. 11,12 (2021): e053373. doi: https://doi.org/10.1136/bmjopen-2021-053373
Gerritsen SE, Maras A, van Bodegom LS, Overbeek MM, Verhulst FC, Wolke D, Appleton R, Bertani A, Cataldo MG, Conti P, Da Fonseca D, Davidović N, Dodig-Ćurković K, Ferrari C, Fiori F, Franić T, Gatherer C, De Girolamo G, Heaney N, Hendrickx G, Kolozsvari A, Levi FM, Lievesley K, Madan J, Martinelli O, Mastroianni M, Maurice V, McNicholas F, O'Hara L, Paul M, Purper-Ouakil D, de Roeck V, Russet F, Saam MC, Sagar-Ouriaghli I, Santosh PJ, Sartor A, Schandrin A, Schulze UME, Signorini G, Singh SP, Singh J, Street C, Tah P, Tanase E, Tremmery S, Tuffrey A, Tuomainen H, van Amelsvoort TAMJ, Wilson A, Walker L, Dieleman GC. Cohort profile: demographic and clinical characteristics of the MILESTONE longitudinal cohort of young people approaching the upper age limit of their child mental health care service in Europe. BMJ Open. 2021 Dec 16;11(12):e053373. doi: 10.1136/bmjopen-2021-053373. PMID: 34916319; PMCID: PMC8679118.
Copy Download .nbib Format: NLM
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach.

NPJ Parkinson's disease

Marques TM, van Rumund A, Kersten I, Bruinsma IB, Wessels HJCT, Gloerich J, Kaffa C, Esselink RAJ, Bloem BR, Kuiperij HB, Verbeek MM.
PMID: 34848724
NPJ Parkinsons Dis. 2021 Nov 30;7(1):107. doi: 10.1038/s41531-021-00249-9.

The aim of our study was to investigate cerebrospinal fluid (CSF) tryptic peptide profiles as potential diagnostic biomarkers for the discrimination of parkinsonian disorders. CSF samples were collected from individuals with parkinsonism, who had an uncertain diagnosis at the...

Cite
Marques TM, van Rumund A, Kersten I, et al. Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach. NPJ Parkinsons Dis. 2021;7(1):107doi: 10.1038/s41531-021-00249-9.
Marques, T. M., van Rumund, A., Kersten, I., Bruinsma, I. B., Wessels, H. J. C. T., Gloerich, J., Kaffa, C., Esselink, R. A. J., Bloem, B. R., Kuiperij, H. B., & Verbeek, M. M. (2021). Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach. NPJ Parkinson's disease, 7(1), 107. https://doi.org/10.1038/s41531-021-00249-9
Marques, Tainá M, et al. "Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach." NPJ Parkinson's disease vol. 7,1 (2021): 107. doi: https://doi.org/10.1038/s41531-021-00249-9
Marques TM, van Rumund A, Kersten I, Bruinsma IB, Wessels HJCT, Gloerich J, Kaffa C, Esselink RAJ, Bloem BR, Kuiperij HB, Verbeek MM. Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach. NPJ Parkinsons Dis. 2021 Nov 30;7(1):107. doi: 10.1038/s41531-021-00249-9. PMID: 34848724.
Copy Download .nbib Format: NLM
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation.

Diagnostics (Basel, Switzerland)

Wagner-Drouet E, Teschner D, Wolschke C, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Hilgendorf I, Klein S, Verbeek M, Ditschkowski M, Koch M, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Wolff D.
PMID: 33671952
Diagnostics (Basel). 2021 Feb 15;11(2). doi: 10.3390/diagnostics11020312.

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Measuring CMV-specific cellular immunity may improve the risk stratification and management of patients. IFN-γ ELISpot assays, based on the stimulation of peripheral...

Cite
Wagner-Drouet E, Teschner D, Wolschke C, et al. Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation. Diagnostics (Basel). 2021;11(2)doi: 10.3390/diagnostics11020312.
Wagner-Drouet, E., Teschner, D., Wolschke, C., Schäfer-Eckart, K., Gärtner, J., Mielke, S., Schreder, M., Kobbe, G., Hilgendorf, I., Klein, S., Verbeek, M., Ditschkowski, M., Koch, M., Lindemann, M., Schmidt, T., Rascle, A., Barabas, S., Deml, L., Wagner, R., & Wolff, D. (2021). Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation. Diagnostics (Basel, Switzerland), 11(2), . https://doi.org/10.3390/diagnostics11020312
Wagner-Drouet, Eva, et al. "Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation." Diagnostics (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/diagnostics11020312
Wagner-Drouet E, Teschner D, Wolschke C, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Hilgendorf I, Klein S, Verbeek M, Ditschkowski M, Koch M, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Wolff D. Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation. Diagnostics (Basel). 2021 Feb 15;11(2). doi: 10.3390/diagnostics11020312. PMID: 33671952; PMCID: PMC7919014.
Copy Download .nbib Format: NLM
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase.

NPJ Parkinson's disease

van Rumund A, Pavelka L, Esselink RAJ, Geurtz BPM, Wevers RA, Mollenhauer B, Krüger R, Bloem BR, Verbeek MM.
PMID: 33741988
NPJ Parkinsons Dis. 2021 Mar 19;7(1):29. doi: 10.1038/s41531-021-00172-z.

Peripheral decarboxylase inhibitors (PDIs) prevent conversion of levodopa to dopamine in the blood by the enzyme aromatic L-amino acid decarboxylase (AADC). Alterations in enzyme activity may contribute to the required higher dosages of levodopa observed in many patients with...

Cite
van Rumund A, Pavelka L, Esselink RAJ, et al. Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinsons Dis. 2021;7(1):29doi: 10.1038/s41531-021-00172-z.
van Rumund, A., Pavelka, L., Esselink, R. A. J., Geurtz, B. P. M., Wevers, R. A., Mollenhauer, B., Krüger, R., Bloem, B. R., & Verbeek, M. M. (2021). Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinson's disease, 7(1), 29. https://doi.org/10.1038/s41531-021-00172-z
van Rumund, Anouke, et al. "Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase." NPJ Parkinson's disease vol. 7,1 (2021): 29. doi: https://doi.org/10.1038/s41531-021-00172-z
van Rumund A, Pavelka L, Esselink RAJ, Geurtz BPM, Wevers RA, Mollenhauer B, Krüger R, Bloem BR, Verbeek MM. Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinsons Dis. 2021 Mar 19;7(1):29. doi: 10.1038/s41531-021-00172-z. PMID: 33741988; PMCID: PMC7979935.
Copy Download .nbib Format: NLM
One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Fagel ND, Amoroso G, Rabbering T, Gescher F, Vink MA, Slagboom T, van der Schaaf RJ, Herrman JR, Patterson MS, Vos NS, Verbeek EC, de Winter RJ, Riezebos RK.
PMID: 34263520
Catheter Cardiovasc Interv. 2021 Nov 01;98(5):E661-E667. doi: 10.1002/ccd.29873. Epub 2021 Jul 15.

OBJECTIVES: We aimed to explore the impact of time to percutaneous coronary intervention (PCI) (T2P) on 1-year mortality in non-ST-elevation myocardial infarction (NSTEMI) patients.BACKGROUND: The current guidelines recommend an early invasive strategy for NSTEMI patients. However, impact of an...

Cite
Fagel ND, Amoroso G, Rabbering T, et al. One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis. Catheter Cardiovasc Interv. 2021;98(5):E661-E667doi: 10.1002/ccd.29873.
Fagel, N. D., Amoroso, G., Rabbering, T., Gescher, F., Vink, M. A., Slagboom, T., van der Schaaf, R. J., Herrman, J. R., Patterson, M. S., Vos, N. S., Verbeek, E. C., de Winter, R. J., & Riezebos, R. K. (2021). One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 98(5), E661-E667. https://doi.org/10.1002/ccd.29873
Fagel, Nick D, et al. "One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 98,5 (2021): E661-E667. doi: https://doi.org/10.1002/ccd.29873
Fagel ND, Amoroso G, Rabbering T, Gescher F, Vink MA, Slagboom T, van der Schaaf RJ, Herrman JR, Patterson MS, Vos NS, Verbeek EC, de Winter RJ, Riezebos RK. One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis. Catheter Cardiovasc Interv. 2021 Nov 01;98(5):E661-E667. doi: 10.1002/ccd.29873. Epub 2021 Jul 15. PMID: 34263520.
Copy Download .nbib Format: NLM
Showing 205 to 214 of 214 entries